MRTX - Mirati Therapeutics EPS misses by $0.13 beats on revenue November, 04 2019 04:49 PM Mirati Therapeutics Inc. Mirati Therapeutics (NASDAQ:MRTX): Q3 GAAP EPS of -$1.38 misses by $0.13.More news on: Mirati Therapeutics, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...